Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-25T01:50:07.368Z Has data issue: false hasContentIssue false

Serum Antioxidant Levels Associated with Subcortical Ischemic Vascular Disease

Published online by Cambridge University Press:  23 September 2014

Xia Zhou
Affiliation:
Department of Neurology, The First Affiliated Hospital of Anhui Medicial University, Anhui Province, People's Republic of China
Long Wang
Affiliation:
Department of Neurology, The First Affiliated Hospital of Anhui Medicial University, Anhui Province, People's Republic of China
Han Liu
Affiliation:
Department of Neurology, The First Affiliated Hospital of Anhui Medicial University, Anhui Province, People's Republic of China
Chao Zhang
Affiliation:
Department of Neurology, The First Affiliated Hospital of Anhui Medicial University, Anhui Province, People's Republic of China
Minmin Zhu
Affiliation:
Department of Neurology, The First Affiliated Hospital of Anhui Medicial University, Anhui Province, People's Republic of China
Xiaoqun Zhu
Affiliation:
Department of Neurology, The First Affiliated Hospital of Anhui Medicial University, Anhui Province, People's Republic of China
Jiahu Hao
Affiliation:
Department of Neurology, The First Affiliated Hospital of Anhui Medicial University, Anhui Province, People's Republic of China
Zhongwu Sun*
Affiliation:
Department of Neurology, The First Affiliated Hospital of Anhui Medicial University, Anhui Province, People's Republic of China
*
*Department of Neurology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Anhui 230022, Anhui Province, People's Republic of China 230022. Email: sunzhwu@hotmail.com
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

We aimed to examine changes in serum bilirubin and uric acid (UA) levels in subcortical ischemic vascular disease (SIVD). In addition, we investigated if altered serum bilirubin and UA levels correlate with the subtypes of SIVD as well as the severity of leukoaraiosis (LA).

Methods:

This cross-sectional study included 1098 consecutive patients with slight symptoms, such as dizziness, vertigo etc. According to magnetic resonance imaging (MRI) appearances, they were divided into either SIVD group or controls (CN), and the SIVD group was further grouped in lacunar infarction (LI) and LA subtypes, as well as different grades. Serum bilirubin and UA levels were determined by the vanadate oxidase method and enzymatic method respectively, after at least an eight hour overnight fasting, in all subjects.

Results:

The bilirubin level was obviously lower while the UA level was significantly higher in the SIVD group when compared with the controls. Moreover, the LA subgroup presented more significant changes in bilirubin and UA when compared to the LI subgroup in both males and females. The correlation was positive between the UA levels and the LA severity (r=0.134, p=0.006). Multivariate regression analysis revealed that the odds ratio (95% CI) for SIVD in the lowest tertile of total bilirubin (Tbil<9.58μmol/L) and highest tertile of UA (UA>339μmol/L) were 2.702(1.936–3.770) and 2.135(1.521–2.996) respectively after adjusting for confounding variables.

Conclusions:

Serum bilirubin levels were lower, whereas UA levels were higher in SIVD patients when compared with controls in both males and females, especially in LA patients. Moreover, serum UA levels positively correlated to LA severity.

Type
Original Article
Copyright
Copyright © The Canadian Journal of Neurological 2014

References

1.Staekenborg, SS, Su, T, van Straaten, EC. Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. J Neurol Neurosurg Psychiatry. 2010 81(5)54751.Google Scholar
2.Erkinjuntti, T. Subcortical vascular dementia. Cerebrovasc Dis. 2002 13 Suppl 25860.CrossRefGoogle ScholarPubMed
3.Jeerakathil, T, Wolf, PA, Beiser, A. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke. 2004 35(8)185761.Google Scholar
4.Al Ahmad, A, Gassmann, M, Ogunshola, OO. Involvement of oxidative stress in hypoxia-induced blood-brain barrier breakdown. Microvasc Res. 2012 84(2)2225.Google Scholar
5.Wengreen, HJ, Munger, RG, Corcoran, CD. Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. J Nutr Health Aging. 2007 11(3)2307.Google Scholar
6.Christen, Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr. 2000 71(2)621S9S.Google Scholar
7.Stocker, R, Yamamoto, Y, McDonagh, AF. Bilirubin is an antioxidant of possible physiological importance. Science. 1987 235(4792)10436.CrossRefGoogle ScholarPubMed
8.Xu, T, Zhang, J, Liu, W. Association of serum bilirubin with stroke severity and clinical outcomes. Can J Neurol Sci. 2013 40(1)804.Google Scholar
9.Sedlak, TW, Saleh, M, Higginson, DS. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci USA. 2009 106(13)51716.Google Scholar
10.Oda, E, Kawai, R. A possible cross-sectional association of serum total bilirubin with coronary heart disease and stroke in a Japanese health screening population. Heart Vessels. 2012 27(1)2936.Google Scholar
11.Spitsin, S, Koprowski, H. Role of uric acid in Alzheimer's disease. J Alzheimers Dis. 2010 19(4)13378.Google Scholar
12.Shen, C, Guo, Y, Luo, W. Serum urate and the risk of Parkinson's disease: results from a meta-analysis. Can J Neurol Sci. 2013 40(1)739.Google Scholar
13.Larina, VN, Bart, Bla, Larin, VG. [Hyperuricemia and cardiovascular continuum]. Klin Med (Mosk). 2013 91(1)115.Google Scholar
14.Tutal, E, Sayin, B, Ertugrul, DT. Is there a link between hyperuricemia, morning blood pressure surge, and non-dipping blood pressure pattern in metabolic syndrome patients?. Int J Nephrol Renovasc Dis. 2013 6 717.Google Scholar
15.Miedema, I, Uyttenboogaart, M, Koch, M. Lack of association between serum uric acid levels and outcome in acute ischemic stroke. J Neurol Sci. 2012 319 1–2515.Google Scholar
16.Fazekas, F, Schmidt, R, Scheltens, P. Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord. 1998 9 Suppl 125.Google Scholar
17.Hoth, KF, Tate, DF, Poppas, A. Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke. 2007 38(2)30812.CrossRefGoogle ScholarPubMed
18.Park, BJ, Shim, JY, Lee, HR. Association between serum total bilirubin level and leukoaraiosis in Korean adults. Clin Biochem. 2012 45 4–528992.Google Scholar
19.Morita, T. Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol. 2005 25(9)178695.CrossRefGoogle ScholarPubMed
20.Ollinger, R, Bilban, M, Erat, A. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation. 2005 112(7)10309.CrossRefGoogle Scholar
21.Erdogan, D, Gullu, H, Yildirim, E. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women. Atherosclerosis. 2006 184(2)4317.Google Scholar
22.Aztatzi-Santillan, E, Nares-Lopez, FE, Marquez-Valadez, B. The protective role of heme oxygenase-1 in cerebral ischemia. Cent Nerv Syst Agents Med Chem. 2010 10(4)3106.CrossRefGoogle ScholarPubMed
23.Kundur, AR, Bulmer, AC, Singh, I. Unconjugated bilirubin inhibits collagen induced platelet activation. Platelets. 2014 25(1)4550.Google Scholar
24.Mazzali, M, Kanellis, J, Han, L. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol. e2002 282(6)F9917.Google Scholar
25.Patterson, RA, Horsley, ET, Leake, DS. Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid. J Lipid Res. 2003 44(3)51221.CrossRefGoogle ScholarPubMed
26.Abuja, PM. Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein. FEBS Lett. 1999 446 2–33058.Google Scholar
27.Bavaresco, CS, Zugno, AI, Tagliari, B. Inhibition of Na+, K+- ATPase activity in rat striatum by the metabolites accumulated in Lesch-Nyhan disease. Int J Dev Neurosc. 2004 22(1)117.Google Scholar
28.Feig, DI. Hyperuricemia and hypertension. Adv Chronic Kidney Dis. 2012 19(6)37785.Google Scholar
29.Richette, P, Perez-Ruiz, F. Serum uric acid and metabolic risk. Curr Med Res Opin. 2013 29 Suppl 3915.Google Scholar
30.Nieto, FJ, Iribarren, C, Gross, MD. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis. 2000 148(1)1319.Google Scholar
31.Schretlen, DJ, Inscore, AB, Jinnah, HA. Serum uric acid and cognitive function in community-dwelling older adults. Neuropsychology. 2007 21(1)13640.Google Scholar
32.Schretlen, DJ, Inscore, AB, Vannorsdall, TD. Serum uric acid and brain ischemia in normal elderly adults. Neurology. 2007 69(14)141823.Google Scholar
33.Kim, SY, Guevara, JP, Kim, KM. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010 62(2)17080.Google Scholar
34.Kim, SY, Guevara, JP, Kim, KM. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009 61(7)88592.Google Scholar
35.Fisher, CM. The arterial lesions underlying lacunes. Acta Neuropathol. 1968 12(1)115.Google Scholar